loading

Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.0653 0.1008 -
Operating Expenses
8.09%
23.08
25.12 33.30 31.48
Benefits Costs and Expenses
-
- - -
Costs And Expenses
8.09%
23.08
25.12 33.30 31.48
Operating Income/Loss
7.85%
-23.08
-25.05 -33.20 -31.48
Income/Loss From Continuing Operations Before Tax
19.42%
-23.52
-19.69 0.1008 -30.47
Income/Loss From Continuing Operations After Tax
19.42%
-23.52
-19.69 -32.24 -30.47
Net Income/Loss
19.42%
-23.52
-19.69 -32.24 -30.47
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
0.56%
38.83
38.61 27.20 23.29
Diluted Average Shares
0.56%
38.83
38.61 27.20 23.29
Basic Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31
Diluted Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):